Modeling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance.

被引：0
|
作者：
Das Thakur, Meghna [1 ]
Fisher, Rosalie [2 ]
Salangsang, Fernando [1 ]
Landman, Allison [3 ]
Sellers, William [4 ]
Pryer, Nancy [1 ]
Levesque, Mitchell Paul [5 ]
Dummer, Reinhard [5 ]
Gore, Martin [2 ]
Larkin, James [2 ]
McMahon, Martin [3 ]
Stuart, Darrin [1 ]
机构：
[1] Novartis, Emeryville, CA USA
[2] Royal Marsden Hosp, London SW3 6JJ, England
[3] UCSF, San Francisco, CA USA
[4] Novartis, Cambridge, MA USA
[5] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-LB-144
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB144
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dual mechanistic function of MDSC subsets in melanoma resistance.
    Borden, E. C.
    Smith, J. Ko
    Rayman, P. A.
    Jacobs, B.
    Ireland, J.
    Lindner, D.
    Finke, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
    Jenny E Hernandez-Davies
    Thai Q Tran
    Michael A Reid
    Kimberly R Rosales
    Xazmin H Lowman
    Min Pan
    Gatien Moriceau
    Ying Yang
    Jun Wu
    Roger S Lo
    Mei Kong
    Journal of Translational Medicine, 13
  • [23] Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
    Hernandez-Davies, Jenny E.
    Tran, Thai Q.
    Reid, Michael A.
    Rosales, Kimberly R.
    Lowman, Xazmin H.
    Pan, Min
    Moriceau, Gatien
    Yang, Ying
    Wu, Jun
    Lo, Roger S.
    Kong, Mei
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [24] Treating Metastatic Melanoma With the BRAF Inhibitor Vemurafenib and Mechanisms of Resistance
    Chapman, P.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S24 - S24
  • [25] Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma
    Trunzer, Kerstin
    Pavlick, Anna C.
    Schuchter, Lynn
    Gonzalez, Rene
    McArthur, Grant A.
    Hutson, Thomas E.
    Moschos, Stergios J.
    Flaherty, Keith T.
    Kim, Kevin B.
    Weber, Jeffrey S.
    Hersey, Peter
    Long, Georgina V.
    Lawrence, Donald
    Ott, Patrick A.
    Amaravadi, Ravi K.
    Lewis, Karl D.
    Puzanov, Igor
    Lo, Roger S.
    Koehler, Astrid
    Kockx, Mark
    Spleiss, Olivia
    Schell-Steven, Annette
    Gilbert, Houston N.
    Cockey, Louise
    Bollag, Gideon
    Lee, Richard J.
    Joe, Andrew K.
    Sosman, Jeffrey A.
    Ribas, Antoni
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (14) : 1767 - 1774
  • [26] In vitro chemosensitivity testing and mechanisms of drug resistance.
    Tewari K.
    Manetta A.
    Current Oncology Reports, 1999, 1 (1) : 77 - 84
  • [27] Uncovering the molecular and energetic basis of drug resistance.
    Dominy, BN
    Brooks, CL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 134 - COMP
  • [28] Overcoming drug resistance in melanoma
    Sosman, J. A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S5 - S5
  • [29] Human melanoma: Drug resistance
    Helmbach, H
    Sinha, P
    Schadendorf, D
    CHEMOSENSITIVITY TESTING IN ONCOLOGY, 2003, 161 : 93 - 110
  • [30] Macrolide resistance. Drug resistance updates (vol 1, pg 29, 1998)
    Weisblum, B
    DRUG RESISTANCE UPDATES, 1998, 1 (02) : 155 - 155
12345